Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Other Non-Current Assets (2020 - 2026)

Climb Bio filings provide 7 years of Other Non-Current Assets readings, the most recent being $1.5 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 1242.11% to $1.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, up 1242.11% year-over-year, with the annual reading at $1.5 million for FY2025, 9462.5% up from the prior year.
  • Other Non-Current Assets hit $1.5 million in Q1 2026 for Climb Bio, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.5 million in Q3 2025 and bottomed at $15000.0 in Q3 2023.
  • Average Other Non-Current Assets over 5 years is $671187.5, with a median of $610500.0 recorded in 2022.
  • The largest annual shift saw Other Non-Current Assets crashed 97.3% in 2023 before it soared 9462.5% in 2025.
  • Climb Bio's Other Non-Current Assets stood at $128000.0 in 2022, then tumbled by 88.28% to $15000.0 in 2023, then rose by 6.67% to $16000.0 in 2024, then soared by 9462.5% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Other Non-Current Assets are $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025).